Physician profile
Luis Alonso Rivera Torres
NPI 1528409679
$1,606.59
in general payments reported to CMS, 2019-2025
5 companies · $979 in 2025
The $979 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.67 · 2021: $272 · 2022: $41.96 · 2023: $127 · 2024: $129 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $550 · Food and Beverage: $535 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $550.00 |
| Food and Beverage | $534.53 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $939.69 | 2024-2025 | Itero Element 5d Plus Lite, Cart Configuration, Invisalign |
| Biohorizons Implant Systems INC. | $546.01 | 2021-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply Sirona INC | $76.14 | 2019-2025 | Astra Tech Implant System |
| Nobel Biocare USA | $30.75 | 2021 | |
| Voco America INC. | $14.00 | 2024 | Profluorid L, Quick Up, Voco Profluorid Varnish |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Rivera Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.